The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

Touro University Nevada is asking for volunteers to take part in a study on the long-term effects of injectable weight-loss or diabetic medication.

The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...

The dramatic rise of weight-loss drugs such as Ozempic and Mounjaro had upended WeightWatchers' business model ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.